The use of telehealth system in improving adherence to nebulised treatment in children with cystic fibrosis: Benefits and pitfalls Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014
Use of an electronic monitoring system to generate objective information on patients’ adherence to taking treatments of a novel inhaled tobramycin solution Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013
Home care and benefit in days of hospitalization, cost and quality of life for children with cystic fibrosis Source: International Congress 2016 – Kaleidoscope of respiratory nursing Year: 2016
Home versus hospital treatment of acute cystic fibrosis pulmonary exacerbations – Is quality of life really better at home? Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013
Implementation of supervised physiotherapy in a school environment in children with cystic fibrosis Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015
Early detection of pulmonary exacerbations in children with cystic fibrosis by electronic home monitoring of symptoms and lung function Source: International Congress 2016 – Cystic fibrosis: monitoring and management Year: 2016
Effect of different physiotherapy devices on ventilation distribution in adults with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013
Knowledge and adherence of airway clearance techniques in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Respiratory physiotherapy: outcomes in disease and health Year: 2015
Nebulised antibiotics with the I-neb adaptive aerosol delivery (AAD) system: Impact on adherence in cystic fibrosis (CF) patients Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems Year: 2012
Implementation of non-medical prescribing within the clinical cystic fibrosis setting Source: International Congress 2014 – Physiotherapy and physical activity in respiratory conditions Year: 2014
Effects of pharmacist interventions to inhalation medication adherence and lung functions in COPD patients at one stop service clinic Source: International Congress 2014 – COPD exacerbations Year: 2014
A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases Year: 2021
Nebuliser hygiene in cystic fibrosis: evidence-based recommendations Source: Breathe, 16 (2) 190328; 10.1183/20734735.0328-2019 Year: 2020
Feasibility study of an intervention to increase treatment adherence in children with cystic fibrosis (CF) Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis Year: 2019
Patients’ opinion for their inhalation device. An assessment of convenience and use Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013
Assessment of NuvoAir platform use on clinical outcomes in adults with cystic fibrosis: a first Italian experience Source: Virtual Congress 2021 – Cystic fibrosis Year: 2021
Optimising treatment policies and improvement of care: impact on outcome in cystic fibrosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 617s Year: 2004
Optimal adherence with inhaled corticosteroids is related to better health status Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015
Compliance with treatment in UK children with cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 538s Year: 2001
Challenges of providing care to adults with cystic fibrosis Source: Eur Respir Monogr 2014; 64: 286-303 Year: 2014